Celularity (CELU) EBT (2019 - 2025)

Celularity (CELU) has reported EBT for 7 consecutive years, with -$24.4 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, EBT fell 83.25% year-over-year to -$24.4 million in Q4 2025; TTM through Dec 2025 was -$91.7 million, a 58.42% decrease from a year earlier, with the FY2025 full-year figure at -$91.7 million, down 58.42% from the prior year.
• EBT was -$24.4 million for Q4 2025 at Celularity, down from -$23.1 million in the prior quarter.
• Over five years, EBT peaked at $49.9 million in Q3 2021 and troughed at -$93.9 million in Q3 2023.
• A 5-year average of -$21.6 million and a median of -$20.9 million in 2024 frame the typical range for EBT.
• Across the five-year window, EBT jumped 708.13% in 2022 and plunged 2063.11% in 2023, its largest moves.
• Over 5 years, EBT stood at -$4.0 million in 2021, then jumped by 708.13% to $24.4 million in 2022, then tumbled by 60.91% to $9.6 million in 2023, then plunged by 239.09% to -$13.3 million in 2024, then plunged by 83.25% to -$24.4 million in 2025.
• The last three EBT figures came in at -$24.4 million (Q4 2025), -$23.1 million (Q3 2025), and -$24.5 million (Q2 2025), per Business Quant data.